[Effect of maternal pharmacological treatment of preterm delivery for neonatal condition].
In article the fetal and neonatal side effects of tocolytic agents were presented. Described the cardiovascular; pulmonary metabolic, neurological and others complications during administration of magnesium sulfate, prostaglandin synthesis inhibitor, calcium channel blockers and oxytocin antagonist.
Kornacka
Maria Katarzyna
MK
Oddział Neonatologii i Intensywnej Terapii Noworodka, II Katedra Połoznictwa i Ginekologii, Akademii Medycznej w Warszawie. mariak@szpitalkarowa.pl
D002121:Calcium Channel Blockers / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008278:Magnesium Sulfate / Q000008:administration & dosage / Q000009:adverse effects; D007752:Obstetric Labor, Premature / Q000188:drug therapy*; D010121:Oxytocin / Q000037:antagonists & inhibitors; D011247:Pregnancy; D011256:Pregnancy Outcome; D011453:Prostaglandins / Q000378:metabolism; D015149:Tocolytic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D014590:Uterine Contraction / Q000187:drug effects*
D002121:Calcium Channel Blockers; D011453:Prostaglandins; D015149:Tocolytic Agents; D010121:Oxytocin; D008278:Magnesium Sulfate